The X-Ray Structure of a BAK Homodimer Reveals an Inhibitory Zinc Binding Site

Molecular Cell

Volumn 24, Issue 5, 2006, Pages 677-688

  Moldoveanu, Tudor ^a   Liu, Qian ^a   Tocilj, Ante ^a   Watson, Mark ^b   Shore, Gordon ^a,b   Gehring, Kalle ^a  

^a MCGILL UNIVERSITY   (Canada)

^b INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

CELLCYCLE

Indexed keywords

BH3 PROTEIN; CYTOCHROME C; HOMODIMER; PROTEIN BAK; PROTEIN BAX; PROTEIN BID; ZINC;

ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING SITE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DIMERIZATION; EMBRYO; ENZYME RELEASE; KNOCKOUT MOUSE; MITOCHONDRION; MOUSE; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; REGULATORY MECHANISM; STRUCTURE ANALYSIS; X RAY ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BINDING SITES; CALPAIN; CHLORIDES; CRYSTALLOGRAPHY, X-RAY; HUMANS; KB CELLS; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; PROTO-ONCOGENE PROTEINS; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; ZINC COMPOUNDS;

DANIO RERIO;

EID: 33751544565     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2006.10.014     Document Type: Article

References (59)

1. Auld D.S. Zinc coordination sphere in biochemical zinc sites. Biometals 14 (2001) 271-313
2. Breckenridge D.G., Germain M., Mathai J.P., Nguyen M., and Shore G.C. Regulation of apoptosis by endoplasmic reticulum pathways. Oncogene 22 (2003) 8608-8618
3. Brünger A.T. Crystallography and NMR system: a new software system for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 45 (1998) 905-921
4. Cao X., Deng X., and May W.S. Cleavage of BAX to p18 BAX accelerates stress-induced apoptosis, and a cathepsin-like protease may rapidly degrade p18 BAX. Blood 102 (2003) 2605-2614
5. Certo M., Del Gaizo Moore V., Nishino M., Wei G., Korsmeyer S., Armstrong S.A., and Letai A. Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. Cancer Cell 9 (2006) 351-365
6. Chen L., Willis S.N., Wei A., Smith B.J., Fletcher J.I., Hinds M.G., Colman P.M., Day C.L., Adams J.M., and Huang D.C. Differential targeting of prosurvival BCL-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol. Cell 17 (2005) 393-403
7. Chen M., He H., Zhan S., Krajewski S., Reed J.C., and Gottlieb R.A. BID is cleaved by calpain to an active fragment in vitro and during myocardial ischemia/reperfusion. J. Biol. Chem. 276 (2001) 30724-30728
8. Chou J.J., Li H., Salvesen G.S., Yuan J., and Wagner G. Solution structure of BID, an intracellular amplifier of apoptotic signaling. Cell 96 (1999) 615-624
9. Cory S., and Adams J.M. The BCL2 family: regulators of the cellular life-or-death switch. Nat. Rev. Cancer 2 (2002) 647-656
10. Danial N.N., and Korsmeyer S.J. Cell death: critical control points. Cell 116 (2004) 205-219
11. Day C.L., Chen L., Richardson S.J., Harrison P.J., Huang D.C., and Hinds M.G. Solution structure of prosurvival MCL-1 and characterization of its binding by proapoptotic BH3-only ligands. J. Biol. Chem. 280 (2005) 4738-4744
12. Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., and Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6 (1995) 277-293
13. DeLano, W.L. (2003). The PyMOL Molecular Graphics System. (http://www.pymol.org).
14. Denisov A.Y., Madiraju M.S., Chen G., Khadir A., Beauparlant P., Attardo G., Shore G.C., and Gehring K. Solution structure of human BCL-w: modulation of ligand binding by the C-terminal helix. J. Biol. Chem. 278 (2003) 21124-21128
15. Denisov A.Y., Chen G., Sprules T., Moldoveanu T., Beauparlant P., and Gehring K. Structural model of the BCL-w-BID peptide complex and its interactions with phospholipid micelles. Biochemistry 45 (2006) 2250-2256
16. Elce J.S., Hegadorn C., Gauthier S., Vince J.W., and Davies P.L. Recombinant calpain II: improved expression systems and production of a C105A active-site mutant for crystallography. Protein Eng. 8 (1995) 843-848
17. 2+ ions. J. Cell Biol. 143 (1998) 217-224
18. Fesik S.W. Insights into programmed cell death through structural biology. Cell 103 (2000) 273-282
19. Ganju N., and Eastman A. Zinc inhibits BAX and BAK activation and cytochrome c release induced by chemical inducers of apoptosis but not by death-receptor-initiated pathways. Cell Death Differ. 10 (2003) 652-661
20. Goping I.S., Gross A., Lavoie J.N., Nguyen M., Jemmerson R., Roth K., Korsmeyer S.J., and Shore G.C. Regulated targeting of BAX to mitochondria. J. Cell Biol. 143 (1998) 207-215
21. Green D.R., and Kroemer G. The pathophysiology of mitochondrial cell death. Science 305 (2004) 626-629
22. Griffiths G.J., Dubrez L., Morgan C.P., Jones N.A., Whitehouse J., Corfe B.M., Dive C., and Hickman J.A. Cell damage-induced conformational changes of the pro-apoptotic protein BAK in vivo precede the onset of apoptosis. J. Cell Biol. 144 (1999) 903-914
23. Griffiths G.J., Corfe B.M., Savory P., Leech S., Esposti M.D., Hickman J.A., and Dive C. Cellular damage signals promote sequential changes at the N-terminus and BH-1 domain of the pro-apoptotic protein BAK. Oncogene 20 (2001) 7668-7676
24. Herberg J.A., Phillips S., Beck S., Jones T., Sheer D., Wu J.J., Prochazka V., Barr P.J., Kiefer M.C., and Trowsdale J. Genomic structure and domain organisation of the human bak gene. Gene 211 (1998) 87-94
25. Hinds M.G., Lackmann M., Skea G.L., Harrison P.J., Huang D.C., and Day C.L. The structure of BCL-w reveals a role for the C-terminal residues in modulating biological activity. EMBO J. 22 (2003) 1497-1507
26. Hsu Y.T., Wolter K.G., and Youle R.J. Cytosol-to-membrane redistribution of BAX and BCL-X(L) during apoptosis. Proc. Natl. Acad. Sci. USA 94 (1997) 3668-3672
27. Johnson B.A. Using NMRView to visualize and analyze the NMR spectra of macromolecules. Methods Mol. Biol. 278 (2004) 313-352
28. Kitamura Y., Shimohama S., Kamoshima W., Ota T., Matsuoka Y., Nomura Y., Smith M.A., Perry G., Whitehouse P.J., and Taniguchi T. Alteration of proteins regulating apoptosis, BCL-2, BCL-x, BAX, BAK, BAD, ICH-1 and CPP32, in Alzheimer's disease. Brain Res. 780 (1998) 260-269
29. Korsmeyer S.J., Shutter J.R., Veis D.J., Merry D.E., and Oltvai Z.N. BCL-2/BAX: a rheostat that regulates an anti-oxidant pathway and cell death. Semin. Cancer Biol. 4 (1993) 327-332
30. Kroemer G., Dallaporta B., and Resche-Rigon M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu. Rev. Physiol. 60 (1998) 619-642
31. Kuwana T., and Newmeyer D.D. BCL-2-family proteins and the role of mitochondria in apoptosis. Curr. Opin. Cell Biol. 15 (2003) 691-699
32. Kuwana T., Mackey M.R., Perkins G., Ellisman M.H., Latterich M., Schneiter R., Green D.R., and Newmeyer D.D. BID, BAX, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 111 (2002) 331-342
33. Kuwana T., Bouchier-Hayes L., Chipuk J.E., Bonzon C., Sullivan B.A., Green D.R., and Newmeyer D.D. BH3 domains of BH3-only proteins differentially regulate BAX-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol. Cell 17 (2005) 525-535
34. Lamzin V.S., and Perrakis A. Current state of automated crystallographic data analysis. Nat. Struct. Biol. 7 Suppl. (2000) 978-981
35. Lok J., and Martin L.J. Rapid subcellular redistribution of BAX precedes caspase-3 and endonuclease activation during excitotoxic neuronal apoptosis in rat brain. J. Neurotrauma 19 (2002) 815-828
36. McDonnell J.M., Fushman D., Milliman C.L., Korsmeyer S.J., and Cowburn D. Solution structure of the proapoptotic molecule BID: a structural basis for apoptotic agonists and antagonists. Cell 96 (1999) 625-634
37. McRee D.E. A visual protein crystallographic software system for X11/XView. J. Mol. Graph. 10 (1992) 44-46
38. 2+ switch aligns the active site of calpain. Cell 108 (2002) 649-660
39. Montessuit S., Mazzei G., Magnenat E., and Antonsson B. Expression and purification of full-length human BAX alpha. Protein Expr. Purif. 15 (1999) 202-206
40. Muchmore S.W., Sattler M., Liang H., Meadows R.P., Harlan J.E., Yoon H.S., Nettesheim D., Chang B.S., Thompson C.B., Wong S.L., et al. X-ray and NMR structure of human BCL-xL, an inhibitor of programmed cell death. Nature 381 (1996) 335-341
41. Murshudov G.N., Vagin A.A., and Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53 (1997) 240-255
42. Nechushtan A., Smith C.L., Lamensdorf I., Yoon S.H., and Youle R.J. BAX and BAK coalesce into novel mitochondria-associated clusters during apoptosis. J. Cell Biol. 153 (2001) 1265-1276
43. Newmeyer D.D., and Ferguson-Miller S. Mitochondria: releasing power for life and unleashing the machineries of death. Cell 112 (2003) 481-490
44. L dimerization by three-dimensional domain swapping. J. Mol. Biol. 356 (2006) 367-381
45. Obonai T., Mizuguchi M., and Takashima S. Developmental and aging changes of BAK expression in the human brain. Brain Res. 783 (1998) 167-170
46. Opferman J.T., and Korsmeyer S.J. Apoptosis in the development and maintenance of the immune system. Nat. Immunol. 4 (2003) 410-415
47. Pagliari L.J., Kuwana T., Bonzon C., Newmeyer D.D., Tu S., Beere H.M., and Green D.R. The multidomain proapoptotic molecules BAX and BAK are directly activated by heat. Proc. Natl. Acad. Sci. USA 102 (2005) 17975-17980
48. Petros A.M., Medek A., Nettesheim D.G., Kim D.H., Yoon H.S., Swift K., Matayoshi E.D., Oltersdorf T., and Fesik S.W. Solution structure of the antiapoptotic protein BCL-2. Proc. Natl. Acad. Sci. USA 98 (2001) 3012-3017
49. Petros A.M., Olejniczak E.T., and Fesik S.W. Structural biology of the BCL-2 family of proteins. Biochim. Biophys. Acta 1644 (2004) 83-94
50. Ruffolo S.C., and Shore G.C. BCL-2 selectively interacts with the BID-induced open conformer of BAK, inhibiting BAK auto-oligomerization. J. Biol. Chem. 278 (2003) 25039-25045
51. Schuler M., and Green D.R. Mechanisms of p53-dependent apoptosis. Biochem. Soc. Trans. 29 (2001) 684-688
52. Suzuki M., Youle R.J., and Tjandra N. Structure of BAX: coregulation of dimer formation and intracellular localization. Cell 103 (2000) 645-654
53. Takano J., Tomioka M., Tsubuki S., Higuchi M., Iwata N., Itohara S., Maki M., and Saido T.C. Calpain mediates excitotoxic DNA fragmentation via mitochondrial pathways in adult brains: evidence from calpastatin mutant mice. J. Biol. Chem. 280 (2005) 16175-16184
54. Terwilliger T.C. Maximum-likelihood density modification. Acta Crystallogr. D Biol. Crystallogr. 56 (2000) 965-972
55. Terwilliger T.C., and Berendzen J. Automated MAD and MIR structure solution. Acta Crystallogr. D Biol. Crystallogr. 55 (1999) 849-861
56. Thompson J.D., Higgins D.G., and Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22 (1994) 4673-4680
57. Vagin A., and Teplyakov A. An approach to multi-copy search in molecular replacement. Acta Crystallogr. D Biol. Crystallogr. 56 (2000) 1622-1624
58. Vaux D.L., and Korsmeyer S.J. Cell death in development. Cell 96 (1999) 245-254
59. Wei M.C., Lindsten T., Mootha V.K., Weiler S., Gross A., Ashiya M., Thompson C.B., and Korsmeyer S.J. tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev. 14 (2000) 2060-2071